Raymond James Downgrades Monopar Therapeutics (MNPR) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: MNPR) | Delayed: 71.95 +2.06 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.89 | 52 Week High | $ | |||
| Open | $70.13 | 52 Week Low | $ | |||
| Day High | $74.02 | P/E | N/A | |||
| Day Low | $70.00 | EPS | $ | |||
| Volume | 151,338 | |||||
